Aripiprazole Treatment of Risperidone-Induced Hyperprolactinemia

View This PDF

NB: This article is only available as a PDF.

Letter to the Editor

Sir: Hyperprolactinemia is a well-recognized complication of some antipsychotic agents that results from the blocking of dopamine-2 (D2) receptors in the anterior pituitary. Aripiprazole, a potent partial agonist of the D2 receptors, inhibits spontaneous prolactin release from isolated anterior pituitary slices. Clinically, switching to aripiprazole monotherapy resolves antipsychoticinduced hyperprolactinemia.

J Clin Psychiatry 2009;70(7):1058-1059

https://doi.org/10.4088/JCP.08l04671